In a world where biotech startups scream for attention, Flurotech operates in silence. With zero web traffic and no public funding rounds, this 11-person Canadian lab is the ultimate stealth operator—yet it commands $1.7M in revenue.

"They don't sell to investors or the public—they sell to the lab next door."

The absence of data is itself data. Zero monthly visits means Flurotech's customers aren't finding them through search engines or social media. Their entire market penetration is driven by direct outreach, trade networks, and word-of-mouth—a classic old-school B2B model in a digital-first world. This is the anti-unicorn playbook: profitable, focused, and invisible.

• Revenue-per-employee ratio suggests high-margin, specialized products or services
• Team composition (CEO, VP of Business Development, Scientific Advisor) indicates a B2B sales and R&D focus
• Complete digital absence suggests a closed-loop, relationship-driven sales model